Pages that link to "Q33670884"

The following pages link to Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching (Q33670884):

Displaying 49 items.

• Clinical and experimental applications of sodium phenylbutyrate (Q24613511) (← links)
• Epigenetic regulation of fetal globin gene expression in adult erythroid cells (Q26864609) (← links)
• Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation (Q28364488) (← links)
• A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies (Q28542998) (← links)
• Induction of human gamma globin gene expression by histone deacetylase inhibitors (Q33598588) (← links)
• Induction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F induction (Q33598612) (← links)
• Future prospects for treatment of hemoglobinopathies (Q33606876) (← links)
• Butyrate increases the efficiency of translation of gamma-globin mRNA. (Q33677601) (← links)
• Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo (Q33922774) (← links)
• Treatment of spinal muscular atrophy by sodium butyrate (Q33933841) (← links)
• Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models (Q34678844) (← links)
• Molecular aspects of embryonic hemoglobin function (Q34719514) (← links)
• Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease (Q34723434) (← links)
• Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo (Q34723868) (← links)
• Pharmacotherapy in sickle cell disease--state of the art and future prospects (Q35220342) (← links)
• Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors (Q35809469) (← links)
• Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation (Q36349164) (← links)
• Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction (Q36445356) (← links)
• Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma (Q36478403) (← links)
• Establishment and regulation of chromatin domains: mechanistic insights from studies of hemoglobin synthesis. (Q36557554) (← links)
• Effects of butyrate and glucocorticoids on gamma- to beta-globin gene switching in somatic cell hybrids (Q36566721) (← links)
• The therapeutic uses of chromatin-modifying agents (Q36822457) (← links)
• Modern treatment of thalassaemia intermedia (Q36848269) (← links)
• Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia (Q36968042) (← links)
• Impact of epigenetic dietary compounds on transgenerational prevention of human diseases (Q37423737) (← links)
• Pharmacologic Induction of Fetal Hemoglobin Production (Q37809339) (← links)
• Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors (Q38025159) (← links)
• Fetal hemoglobin reactivation in baboon and man: A short perspective (Q38573730) (← links)
• Butyrate-induced reactivation of the fetal globin genes: A molecular treatment for theβ-hemoglobinophaties (Q40485112) (← links)
• 7 Increased HbF in adult life (Q40489117) (← links)
• 5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells (Q40640479) (← links)
• Beta globin gene inhibition by antisense RNA transcripts (Q40897335) (← links)
• Novel treatment options in the severe beta-globin disorders (Q40938157) (← links)
• Abrogation of IL-3 Requirements and Stimulation of Hematopoietic Cell Proliferationin Vitroandin Vivoby Carboxylic Acids (Q41067313) (← links)
• Stopping the biologic clock for globin gene switching (Q41209359) (← links)
• Pathogenesis and Treatment of Sickle Cell Disease (Q41587302) (← links)
• Sodium Butyrate and Valproic Acid as Splicing Restoring Agents in Erythroid Cells of β-Thalassemic Patients (Q41674208) (← links)
• Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. (Q42709676) (← links)
• Butyrate induces expression of transfected human fetal and endogenous mouse embryonic globin genes in GM 979 erythroleukemia cells (Q43917628) (← links)
• Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate (Q44066886) (← links)
• Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expression (Q44366699) (← links)
• The histone deacetylase inhibitor, trichostatin A, reactivates the developmentally silenced γ globin expression in somatic cell hybrids and induces γ gene expression in adult BFUe cultures (Q44434610) (← links)
• Postnatal transition of γ-globin gene expression in normal Japanese population (Q45038164) (← links)
• Novel approaches to treatment of sickle cell anaemia (Q45873795) (← links)
• Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies (Q47720716) (← links)
• Fetal gene reactivation (Q47739236) (← links)
• Fetal lung mRNA levels of Hox genes are differentially altered by maternal diabetes and butyrate in rats. (Q52185990) (← links)
• A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders (Q72066782) (← links)
• Polycythaemia in Infants of Diabetic Mothers: β-Hydroxybutyrate Stimulates Erythropoietic Activity (Q84702136) (← links)